Acurx Pharmaceuticals, Inc. (ACXP) vs Alzamend Neuro Inc (ALZN)
A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Alzamend Neuro Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACXP
Acurx Pharmaceuticals, Inc.
$1.31HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ALZN
Alzamend Neuro Inc
$1.41HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACXP vs ALZN
growth of $100 · dividends reinvested · last 5yACXP -99.2% (-61.6%/yr)ALZN -100.0% (-83.5%/yr)ACXP compounded faster over this window
Log scale — wide-divergence pair
ACXP ALZN
ACXP vs ALZN: by the numbers
- •ACXP is the larger company ($6M vs $5M market cap).
Metrics side by side
Valuation
| Metric | ACXP | ALZN |
|---|---|---|
| P/B ratio | 0.69 | 0.92 |
Profitability
| Metric | ACXP | ALZN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -92.08% | -156.77% |
| ROIC | -94.08% | -156.69% |
Growth (annualized)
| Metric | ACXP | ALZN |
|---|---|---|
| Total return CAGR (5Y) | -57.41% | -79.14% |
Frequently asked
- How have ACXP and ALZN total returns compared?
- Over the past 5 years, ACXP delivered -57.41% and ALZN delivered -79.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.